KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Oct 29, 2019 $0.0510 $0.0529 $0.0410 $0.0487 13 732
Oct 28, 2019 $0.0500 $0.0550 $0.0400 $0.0500 106 797
Oct 25, 2019 $0.0583 $0.0583 $0.0457 $0.0500 76 286
Oct 24, 2019 $0.0400 $0.0600 $0.0390 $0.0390 66 992
Oct 23, 2019 $0.0393 $0.0600 $0.0391 $0.0500 4 453
Oct 22, 2019 $0.0395 $0.0555 $0.0395 $0.0555 30 752
Oct 21, 2019 $0.0385 $0.0660 $0.0385 $0.0600 9 231
Oct 18, 2019 $0.0490 $0.0630 $0.0390 $0.0590 7 237
Oct 17, 2019 $0.0560 $0.0700 $0.0410 $0.0600 67 000
Oct 16, 2019 $0.0420 $0.0560 $0.0420 $0.0560 2 083
Oct 15, 2019 $0.0580 $0.0580 $0.0390 $0.0560 2 776
Oct 14, 2019 $0.0390 $0.0580 $0.0390 $0.0485 6 065
Oct 11, 2019 $0.0390 $0.0600 $0.0390 $0.0552 11 703
Oct 10, 2019 $0.0360 $0.0600 $0.0360 $0.0600 10 576
Oct 09, 2019 $0.0400 $0.0600 $0.0400 $0.0600 15 750
Oct 08, 2019 $0.0750 $0.0750 $0.0390 $0.0650 36 207
Oct 07, 2019 $0.0360 $0.0606 $0.0360 $0.0480 11 417
Oct 04, 2019 $0.0450 $0.0480 $0.0390 $0.0480 14 738
Oct 03, 2019 $0.0281 $0.0479 $0.0281 $0.0473 996
Oct 02, 2019 $0.0390 $0.0480 $0.0390 $0.0480 1 850
Oct 01, 2019 $0.0400 $0.0480 $0.0390 $0.0480 58 815
Sep 30, 2019 $0.0445 $0.0500 $0.0390 $0.0500 3 793
Sep 27, 2019 $0.0391 $0.0500 $0.0390 $0.0500 22 653
Sep 26, 2019 $0.0500 $0.0500 $0.0390 $0.0500 9 138
Sep 25, 2019 $0.0400 $0.0500 $0.0390 $0.0500 7 245
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT